Texas A&M Researcher Uses ‘Brita Filter For Blood’ To Save Horses From Sepsis
Originally developed to treat human patients with COVID-19, hemoperfusion may be the new answer to treating horses with sepsis, snakebites, and other blood-related conditions. Sepsis, a severe reaction to a bacterial infection, is among the most common and life-threatening conditions in horses, especially foals, whose immune systems are still developing. Approximately 60-70% of horses with […]
Texas A&M’s New Hemoperfusion Clinical Trial Offers Hope For Large Animal Patients
Jet Black Dasher, a quarter horse mare, arrived at the Texas A&M Large Animal Teaching Hospital (LATH) in critical condition, with numerous rapid-onset symptoms resulting from liver disease. But after becoming the hospital’s first patient to receive an innovative hemoperfusion treatment as part of a new clinical trial, the 4-year-old mare has a second chance […]
Success Of Texas A&M-Led Clinical Trial Offers New Hope For Dogs With Herniated Discs
To learn more about the clinical trial for a new, non-surgical IVDD/herniated disc treatment, including eligibility and contact information, please visit the VMBS Office of Veterinary Clinical Investigation’s StudyPages account. A new non-invasive treatment — developed by a Texas A&M faculty member and offered only at Texas A&M — appears to be as effective as surgery […]
Human Clinical Trial Begins For Texas A&M-Discovered Drug To Treat Angelman Syndrome
Developed by biopharmaceutical company Ultragenyx, GTX-102 is the first clinically developed drug targeting the genetic causes of Angelman syndrome rather than symptoms. The first therapeutic drug for Angelman syndrome (AS) — discovered by Texas A&M researchers — has begun human trials, bringing it one step closer to potentially becoming available to patients. GTX-102 was discovered […]
Dog Aging Project Receives $7 Million NIH Grant To Expand Clinical Trial Of Anti-Aging Drug
The study seeks to determine whether rapamycin increases the lifespan of dogs, with the hope that it may also help extend human lives. Researchers led by the Texas A&M College of Veterinary Medicine & Biomedical Sciences (VMBS) have received $7 million from the National Institutes of Health (NIH) to expand a clinical trial studying rapamycin’s […]
Greenlighting Cancer Research: New Insulinoma Treatment Gives Beloved Dog Second Chance At Life
You never know when the relationships you make in school will turn into lasting friendships…or when those friendships could end up saving a life. For Dr. Kelley Thieman Mankin and Dr. Heather Hendrickson, a small animal veterinarian in St. Louis, Missouri, their friendship began during veterinary school at the University of Missouri. “We were in […]
Texas A&M Veterinary Clinical Trial Gives Tabby Cat With Chronic Kidney Disease A Second Chance At Life
Unlike the tender variety of Japanese beef that he’s named for, Kobe has always been one tough tabby. The now 14-year-old male has overcome numerous obstacles in life, including a rough start as a kitten and a weight loss journey from 28 pounds down to 12. “I was 8 years old when my mom found […]
Dachshund Recovers From Herniated Disc Following New, Non-Surgical Treatment
In order to be considered for the clinical trial of the new, non-surgical IVDD/herniated disk treatment, dogs must be seen by the Small Animal Teaching Hospital within three days of the onset of symptoms. For more information, please contact the Texas A&M Office of Veterinary Clinical Investigation at vetclinicaltrials@tamu.edu. When Oscar, a 5-year-old Dachshund, developed partial paralysis from […]
